| Inhibition of Hsp90 suppresses PI3K/AKT/mTOR signaling and has antitumor activity in Burkitt lymphoma L Giulino-Roth, HJ van Besien, T Dalton, JE Totonchy, A Rodina, ... Molecular cancer therapeutics 16 (9), 1779-1790, 2017 | 69 | 2017 |
| Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypes H Scholze, RE Stephenson, R Reynolds, S Shah, R Puri, SD Butler, ... Blood advances 4 (20), 5226-5231, 2020 | 33 | 2020 |
| Microwave Spectra of the Deuterium Isotopologues of cis-Hexatriene and a Semiexperimental Equilibrium Structure NC Craig, Y Chen, HA Fuson, H Tian, H van Besien, AR Conrad, ... The Journal of Physical Chemistry A 117 (39), 9391-9400, 2013 | 17 | 2013 |
| Antileukemic properties of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors H Van Besien, A Sassano, JK Altman, LC Platanias Leukemia & Lymphoma 54 (12), 2601-2605, 2013 | 15 | 2013 |
| Combined ezh2 and bcl2 inhibitors as precision therapy for genetically defined dlbcl subtypes D Gibbs, H Van Besien, S Regan, A Singh, M Teater, E Cesarman, ... Blood 134, 304, 2019 | 5 | 2019 |
| Arrhythmic complications associated with cancer therapies NVK Pothineni, H Van Besien, MG Fradley Heart Failure Clinics 18 (3), 375-383, 2022 | 2 | 2022 |
| Analysis of the rotational structure in the high-resolution infrared spectra of trans-hexatriene-2-d1 and-3-d1 NC Craig, Y Chen, H van Besien, TA Blake Journal of Molecular Spectroscopy 303, 26-35, 2014 | 1 | 2014 |
| Long Term Neurologic Outcomes for Patients Receiving CAR-T Therapy for Non-Hodgkin’s Lymphoma Who Developed Severe Neurotoxicity H van Besien, DL Porter, SD Nasta, J Svoboda, SK Barta, SJ Schuster, ... 2023 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2023 | | 2023 |
| Targeting Metabolic Vulnerabilities in Primary Effusion Lymphoma Using the Novel Nucleoside Analog 6-Eti J Sadek, J Krumsiek, T Zhang, B Coan, MI de Garayo, T Dalton, ... Blood 138, 1188, 2021 | | 2021 |
| Abstract PO-53: Combined EZH2 and BCL2 inhibitors as precision therapy for genetically defined DLBCL subtypes H Scholze, RE Stephenson, R Reynolds, S Shah, R Puri, MR Teater, ... Blood Cancer Discovery 1 (3_Supplement), PO-53-PO-53, 2020 | | 2020 |
| Targeting the Hsp90 Oncoproteome in Burkitt Lymphoma LG Roth, H van Besien, A Rodina, T Taldone, H Erdjument-Bromage, ... Blood 126 (23), 592, 2015 | | 2015 |
| A Semiexperimental Equilibrium Structure of cis-Hexatriene from Microwave Spectroscopy NC Craig, Y Chen, HA Fuson, H Tian, H van Besien, HD Rudolph, ... 68th International Symposium on Molecular Spectroscopy, ERK02, 2013 | | 2013 |
| Microwave Spectra of Deuterium Isotopologues of cis-HEXATRIENE NC Craig, HA Fuson, H Tian, H van Besien, RA Conrad, MJ Tubergen 67th International Symposium on Molecular Spectroscopy, TH06, 2012 | | 2012 |
